The impact of macular edema on visual function in intermediate, posterior, and panuveitis

Ocular Immunology and Inflammation

Volumn 20, Issue 3, 2012, Pages 171-181

  Taylor, Simon R J ^a,b   Lightman, Susan L ^b   Sugar, Elizabeth A ^c   Jaffe, Glen J ^d   Freeman, William R ^e   Altaweel, Michael M ^f   Kozak, Igor ^e   Holbrook, Janet T ^c   Jabs, Douglas A ^c,g,h   Kempen, John H ⁱ  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d DUKE UNIVERSITY EYE CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ University of California San Diego ^*  (United States)

Author keywords

Cataract; Cystoid macular edema; OCT; Uveitis; Visual acuity; Visual field, vitrectomy

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; RETINA MACULA EDEMA; UVEITIS; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

ADULT; FEMALE; FLUORESCEIN ANGIOGRAPHY; GLAUCOMA; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PANUVEITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TOMOGRAPHY, OPTICAL COHERENCE; UVEITIS, INTERMEDIATE; VISUAL ACUITY; VISUAL FIELDS; VISUAL PERCEPTION;

EID: 84860534790     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2012.658467     Document Type: Article

References (33)

1. Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. Jul-Aug 2004;218(4): 223-236. (Pubitemid 38969828)
2. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular infammatory disease. Br J Ophthalmol. Apr 1996;80(4):332-336. (Pubitemid 26113585)
3. Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. Sep 2004;88(9):1159-1162. (Pubitemid 39141376)
4. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. Oct 1990;14(5-6):303-308. (Pubitemid 20350862)
5. Sivaprasad S, Ikeji F, Xing W, Lightman S. Tomographic assessment of therapeutic response to uveitic macular oedema. Clin Experiment Ophthalmol. Nov 2007;35(8): 719-723. (Pubitemid 350090528)
6. Alasil T, Keane PA, Updike JF, et al. Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology. Dec 2010;117(12):2379-2386.
7. Brar M, Yuson R, Kozak I, et al. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema. Retina. Mar 2010;30(3):383-389.
8. Markomichelakis NN, Halkiadakis I, Pantelia E, et al. Course of macular edema in uveitis under medical treatment. Ocul Immunol Infamm. Mar-Apr 2007;15(2):71-79. (Pubitemid 46897690)
9. Markomichelakis NN, Halkiadakis I, Pantelia E, et al. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. Ophthalmology. May 2004;111(5): 946-953. (Pubitemid 38586689)
10. Shukla D, Behera UC, Chakraborty S, Mahalakshmi R, Prasad NM. Serous macular detachment as a predictor of resolution of macular edema with intravitreal triamcino-lone injection. Ophthalmic Surg Lasers Imaging. Mar-Apr 2009;40(2):115-119.
11. Tran TH, de Smet MD, Bodaghi B, Fardeau C, Cassoux N, Lehoang P. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fuorescein angiography. Br J Ophthalmol. Jul 2008;92(7):922-927. (Pubitemid 351969671)
12. Kiss CG, Barisani-Asenbauer T, Simader C, Maca S, Schmidt-Erfurth U. Central visual feld impairment during and following cystoid macular oedema. Br J Ophthalmol. Jan 2008;92(1):84-88.
13. Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Sugar EA. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol. Apr 2010;149(4):550-561 e510.
14. Callanan DG, Jaffe GJ, Martin DF, Pearson PA, Comstock TL. Treatment of posterior uveitis with a fuocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol. Sep 2008;126(9):1191-1201.
15. Jaffe GJ, Martin D, Callanan D, Pearson PA, Levy B, Comstock T; Fluocinolone Acetonide Uveitis Study Group. Fluocinolone acetonide implant (Retisert) for non-infectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology. Jun 2006;113(6):1020-1027. (Pubitemid 43795240)
16. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular infammatory disorders: recommendations of an expert panel. Am J Ophthalmol. Oct 2000;130(4):492-513.
17. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. Sep 2005;140(3):509-516. (Pubitemid 41224845)
18. Ferris FL, 3rd, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. Jul 1982;94(1):91-96. (Pubitemid 12080556)
19. Ferris FL, 3rd, Sperduto RD. Standardized illumination for visual acuity testing in clinical research. Am J Ophthalmol. Jul 1982;94(1):97-98.
20. Antcliff RJ, Stanford MR, Chauhan DS, et al. Comparison between optical coherence tomography and fundus fuorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology. Mar 2000;107(3):593-599 (Pubitemid 30191384)
21. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. Dec 1985;103(12):1796-1806.
22. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. Mar 1986;42(1): 121-130.
23. Little RJ, Rubin DB. Statistical analysis with missing data. In: Statistical Analysis with Missing Data. Hoboken, NJ: Wiley; 2002:85-87.
24. Lardenoye CW, van Kooij B, Rothova A. Impact of macu-lar edema on visual acuity in uveitis. Ophthalmology. Aug 2006;113(8):1446-1449. (Pubitemid 44108170)
25. de Smet MD, Taylor SR, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res Nov 2011;30(6):452-470.
26. Kiss CG, Barisani-Asenbauer T, Maca S, Richter-Mueksch S, Radner W. Reading performance of patients with uveitis-associated cystoid macular edema. Am J Ophthalmol. Oct 2006;142(4):620-624.
27. Charbel Issa P, Helb HM, Holz FG, Scholl HP; MacTel Study Group. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia. Am J Ophthalmol. Jan 2008;145(1):169-175.
28. Jivrajka RV, Kim JK, Fink W, Sadun AA, Sebag J. Quantitative analysis of central visual feld defects in macular edema using three-dimensional computer-automated threshold Amsler grid testing. Graefes Arch Clin Exp Ophthalmol. Feb 2009;247(2):165-170.
29. Okada K, Yamamoto S, Mizunoya S, Hoshino A, Arai M, Takatsuna Y. Correlation of retinal sensitivity measured with fundus-related microperimetry to visual acuity and retinal thickness in eyes with diabetic macular edema. Eye (Lond). Jul 2006;20(7):805-809. (Pubitemid 44316989)
30. Vujosevic S, Midena E, Pilotto E, Radin PP, Chiesa L, Cavarzeran F. Diabetic macular edema: correlation between microperimetry and optical coherence tomography fndings. Invest Ophthalmol Vis Sci. Jul 2006;47(7):3044-3051. (Pubitemid 351639784)
31. van Kooij B, Probst K, Fijnheer R, Roest M, de Loos W, Rothova A. Risk factors for cystoid macular oedema in patients with uveitis. Eye (Lond). Feb 2008;22(2):256-260. (Pubitemid 351266468)
32. Lin P, Loh AR, Margolis TP, Acharya NR. Cigarette smoking as a risk factor for uveitis. Ophthalmology. Mar 2010;117(3):585-590.
33. Thorne JE, Daniel E, Jabs DA, Kedhar SR, Peters GB, Dunn JP. Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol. May 2008;145(5):841-846.